Current Pharmaceutical Design
Title:Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy
Volume: 23 Issue: 35
Author(s): Ahmed O. Elzoghby *
Affiliation:
- Director of Cancer Nanotechnology Research Laboratory (CNRL) Department of Industrial Pharmacy Faculty of Pharmacy Alexandria University, Alexandria 21521,Egypt
Export Options
About this article
Cite this article as:
Elzoghby O. Ahmed*, Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy, Current Pharmaceutical Design 2017; 23 (35) . https://dx.doi.org/10.2174/1381612823999171106125801
DOI https://dx.doi.org/10.2174/1381612823999171106125801 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
33
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hepatocellular Carcinoma Detection by Gallium Scan and Subsequent Treatment by Gallium Maltolate: Rationale and Case Study
Anti-Cancer Agents in Medicinal Chemistry Oleacein. Translation from Mediterranean Diet to Potential Antiatherosclerotic Drug
Current Pharmaceutical Design New Perspectives of HIV/AIDS Therapy Study
Recent Patents on Anti-Infective Drug Discovery Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Current Drug Delivery Cancer and Aids: New Trends in Drug Design and Chemotherapy
Current Computer-Aided Drug Design Comparison of Glucocorticoid Receptor- and Epigenetically Regulated Genes in Proliferating Versus Growth-Arrested Neuro-2a Cells
CNS & Neurological Disorders - Drug Targets Recent Progress in Selenophenes Synthesis from Inorganic Se-Precursors
Current Organic Synthesis Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine Modulation of Protein-Protein Interactions as a Therapeutic Strategy for the Treatment of Neurodegenerative Tauopathies
Current Topics in Medicinal Chemistry Antioxidant Therapy in Alzheimers Disease: Theory and Practice
Mini-Reviews in Medicinal Chemistry Dysfunction of Mitochondrial ATP Production As a Target for Personalized Cancer Therapy
Current Pharmacogenomics and Personalized Medicine Synthesis and Cytotoxicity Studies of New Morpholino-Functionalised and N-Heteroaryl-Substituted Titanocene Anticancer Drugs
Medicinal Chemistry Synthesis and Preliminarily Cytotoxicity to A549, HCT116 and MCF-7 Cell Lines of thieno[2,3-d]pyrimidine Derivatives Containing Isoxazole Moiety
Letters in Drug Design & Discovery Functions of S100 Proteins
Current Molecular Medicine Analysis of Differential Gene Expression Based on Bayesian Estimation of Variance
Current Bioinformatics Acknowledgements to Reviewers
Recent Patents on Anti-Cancer Drug Discovery Meet Our Associate Editorial Board Member
Current Nanomedicine Strategic Combination Therapies for Ovarian Cancer
Current Cancer Drug Targets Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions
Current Drug Metabolism Elucidating Molecular Interactions of Ten Natural Compounds Targeting E6 HPV High Risk Oncoproteins Using Microsecond Molecular Dynamics Simulations
Medicinal Chemistry